Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
about
Does it make sense to develop new centrally acting cardiovascular drugs?Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension.Differential central NOS-NO signaling underlies clonidine exacerbation of ethanol-evoked behavioral impairmentAdrenoceptors of the medial septal area modulate water intake and renal excretory function induced by central administration of angiotensin II.
P2860
Nitric oxide and central antihypertensive drugs: one more difference between catecholamines and imidazolines.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Nitric oxide and central antih ...... techolamines and imidazolines.
@ast
Nitric oxide and central antih ...... techolamines and imidazolines.
@en
type
label
Nitric oxide and central antih ...... techolamines and imidazolines.
@ast
Nitric oxide and central antih ...... techolamines and imidazolines.
@en
prefLabel
Nitric oxide and central antih ...... techolamines and imidazolines.
@ast
Nitric oxide and central antih ...... techolamines and imidazolines.
@en
P2093
P356
P1433
P1476
Nitric oxide and central antih ...... techolamines and imidazolines.
@en
P2093
P304
P356
10.1161/01.HYP.37.2.246
P407
P577
2001-02-01T00:00:00Z